The global hydronephrosis treatment market size is expected to grow from USD 2 billion to USD 4.31 billion in 10 years. The market is expected to grow rapidly due to technological advancements in imaging technology during the forecast period.
NEWARK, April 29, 2024 (GLOBE NEWSWIRE) — Brainy Insights estimates the global hydronephrosis treatment market to be USD 2 billion in 2023 and reach USD 4.31 billion in 2033. I am. Both kidneys due to urine accumulation. This occurs when the flow of urine is obstructed by a kidney stone, tumor, urinary tract infection, birth defect, or scar tissue. The degree of hydronephrosis and the underlying etiology determine the treatment strategy. Pain management is often the first course of action. It is essential to resolve the underlying issues. For example, shock wave lithotripsy can be used to destroy kidney stones, or surgery can be used to remove kidney stones. In some situations, a ureteral stent may be placed to help the flow of urine, but in other cases surgery may be required to remove the blockage or correct an anatomical problem. Treatment of hydronephrosis is necessary to preserve kidney function and prevent further kidney damage. If left untreated, problems such as kidney damage, infection, and kidney failure can occur. Treatment is to reduce symptoms, preserve kidney function, and improve quality of life by addressing the underlying cause and restoring normal urine flow.
Full study available now | Download sample page of this report @ https://www.thebrainyinsights.com/enquiry/sample-request/14218
Hydronephrosis Treatment Market Scope
|
Report scope |
detail |
|
CAGR |
8% from 2024 to 2033 |
|
Market size in 2023 |
2 billion USD |
|
Market size by 2033 |
$4.31 billion |
|
biggest market |
North America |
|
base year |
2023 |
|
Forecast year |
From 2024 to 2033 |
|
historic year |
2020-2022 |
|
Target segment |
By type, diagnosis, treatment, indication, region |
|
Target area |
North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
.
Key Insights into the Global Hydronephrosis Treatment Market
North America will dominate the market during the forecast period.
The region’s advanced medical infrastructure, including modern hospitals and access to state-of-the-art technology, gives medical professionals a wide range of options for diagnosing and treating hydronephrosis. In addition, North America is home to pharmaceutical companies, medical device manufacturers, and research institutions dedicated to medical advancement and the development of new treatments for urinary disorders. Specialist physicians play an important role in the region’s leadership in the treatment of hydronephrosis. North America spends a lot of money on health care, and the United States in particular invests heavily in patient care, medical research, and technology. This significant investment will help ensure access to cutting-edge treatment options and resources for efficient hydronephrosis management.
In 2023, the one-sided segment dominated the market with a market share of 57% and a revenue of 1.14 billion.
Type segments are divided into unilateral and bilateral. In 2023, the one-sided segment dominated the market, registering the largest market share of 57% and revenue of 1.14 billion.
In 2023, the imaging segment dominated the market with a market share of 64% and revenue of 1.28 billion.
The diagnostic segment is divided into clinical examination and imaging. In 2023, the imaging segment dominated the market, with the largest market share of 64% and revenue of his 1.28 billion.
In 2023, the shockwave lithotripsy segment dominated the market with a market share of 40% and revenue of $800 million.
Treatment areas are divided into shock wave lithotripsy, laparoscopy, bladder catheterization, and steroid therapy. In 2023, the shock wave lithotripsy segment dominated the market with a market share of 40% and revenue of $800 million.
In 2023, the essential segment dominated the market with 60% market share and revenue of 1.2 billion.
Instruction segments are divided into internal and external segments. In 2023, the essential segment dominated the market with the largest market share of 60% and revenue of 1.2 billion.
Customize your customization here: https://www.thebrainyinsights.com/enquiry/request-customization/14218
market progress
Under the guidance of expert Dr. Mallikarjuna Reddy, senior consultant and head of urology and robotic surgeon at Civil Specialist Hospital, Hyderabad, advanced pediatric robotic surgery was performed on a 21-day-old baby girl diagnosed with bilateral disease. I was disappointed. Hydronephrosis. According to a hospital statement, Baby is the first and youngest patient in India to undergo robotic kidney surgery.
Market trend
Driver: The prevalence of kidney failure is increasing.
Obesity has gradually increased over the past decades and is generally recognized as a risk factor for the development of hydronephrosis and the diseases that lead to it. Obesity also plays a role in the development of kidney stones, as obesity is associated with insulin resistance, metabolic syndrome, and changes in urine composition, all of which increase the risk of kidney stones. In addition, hormonal abnormalities associated with obesity can lead to hydronephrosis and prostate enlargement. The correlation between hydronephrosis-related diseases and obesity highlights the increasing prevalence of hydronephrosis. Therefore, the growing demand for hydronephrosis treatment is highlighted by the rising obesity rates worldwide, which also increases the burden of hydronephrosis-related diseases.
Restraints: Hydronephrosis treatment is expensive in nature.
The high cost of diagnostic procedures such as CT, MRI, and ultrasound scans can prevent patients from receiving the care they need, especially in areas with little access to comprehensive insurance or ancillary medical services. . Treatment costs such as prescription drugs, surgery, and aftercare add to the financial burden. Total costs are influenced by prescription medications needed to treat the underlying hydronephrosis-related disease and manage symptoms. Indirect expenses such as lost income due to missed work due to medical appointments and travel expenses further increase the financial burden. Therefore, the high cost of hydronephrosis treatment will limit the market expansion.
Opportunity: Advances in imaging technology.
Advances in medical imaging techniques such as CT, MRI, and ultrasound have greatly improved our ability to identify and treat hydronephrosis. Early detection or diagnosis allows for prompt intervention and treatment, avoiding problems such as kidney damage and infection. The availability of screening programs and improved knowledge about kidney health issues have also aided in early detection and subsequent affordable and successful treatment. Thanks to improved diagnostic methods, increased awareness, and screening efforts, more cases of hydronephrosis are being detected earlier. As a result, there is now an increased need for prompt intervention and care. Increased awareness, increased access to screening programs, and further improvements in diagnostic capabilities will all help drive market expansion during the forecast period.
Challenge: Limited awareness of hydronephrosis.
Lack of awareness by healthcare providers can lead to underdiagnosis or misdiagnosis of hydronephrosis. As a result, patients may undergo unnecessary testing or treatment, or their condition may go undetected and diagnosis and treatment may be delayed. Additionally, health care providers may not know all available treatments for hydronephrosis. This may delay implementation of an appropriate treatment plan. Limited awareness about hydronephrosis among the general population may prevent individuals from recognizing symptoms or seeking medical attention when they occur. Therefore, limited awareness regarding hydronephrosis will pose a challenge to market growth.
If you would like to place an order or have any questions, please feel free to contact us at sales@thebrainyinsights.com. +1-315-215-1633
The key companies operating in the global Hydronephrosis Treatment market are:
• Allergan
• American Renal Associates
• Amgen
• Anthem Bio Farm
• Merck
• Nephrogenex Co., Ltd.
• Novartis AG
• Fluxis Co., Ltd.
• Renal Associates Pennsylvania
• Sanofi
Key segments covered in the market:
By type
• Unilateral
• Bilateral
by diagnosis
• Laboratory tests
• Imaging
By treatment
• Shock wave lithotripsy
• Laparoscopy
• Bladder catheter treatment
• Steroid therapy
By indication
• essential
• External
By region
• North America (USA, Canada, Mexico)
• Europe (Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and other South America)
• Middle East and Africa (UAE, South Africa, rest of MEA)
Same day delivery available | Buy this premium research report @ https://www.thebrainyinsights.com/buy-now/14218/single
About the report:
The market is analyzed on the basis of value (USD Billion). All segments are analyzed on global, regional and country basis. The study includes analysis of more than 30 countries in each part. The report analyzes drivers, opportunities, constraints, and challenges to gain key market insights. This research includes Porter’s Five Forces Model, attractiveness analysis, product analysis, supply and demand analysis, competitive position grid analysis, distribution, and marketing channel analysis.
About Brainy Insights:
The Brainy Insights is a market research company that provides actionable insights to improve business acumen for companies through data analysis. They have robust predictive and estimation models to achieve their clients’ goals of achieving high-quality results in a short period of time. We offer both customized (client-specific) and syndicated reports. The repository of syndicated reports is diverse across all categories and subcategories across domains. Their customized solutions meet clients’ requirements, whether they are looking to expand in global markets or planning to launch a new product.
inquiry
Avinash D
Business development manager
Phone: +1-315-215-1633
Email: sales@thebrainyinsights.com
Web: http://www.thebrainyinsights.com
